Skip to main content
TipRanks
Go Ultimate75% OFF

Ascelia Pharma AB (7ZA) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Ascelia Pharma AB has a market cap or net worth of EUR 6.97M. The enterprise value is EUR 78.24M.

Market Cap
EUR 6.97M
Enterprise Value
EUR 78.24M

Share Statistics

Ascelia Pharma AB has 133,535,460 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
133,535,460
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Ascelia Pharma AB’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -73.35%.

Return on Equity (ROE)
-0.77
Return on Assets (ROA)
-0.68
Return on Invested Capital (ROIC)
-73.35%
Return on Capital Employed (ROCE)
-0.74
Revenue Per Employee
0
Profits Per Employee
-7.63M
Employee Count
10
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Ascelia Pharma AB is -1.34. Ascelia Pharma AB’s PEG ratio is -0.02.

PE Ratio
-1.34
PS Ratio
0.00
PB Ratio
0.94
Price to FCF
-1.26
Price to Operating Cash Flow
-1.21
PEG Ratio
-0.02

Income Statement

In the last 12 months, Ascelia Pharma AB had revenue of 0 and earned -76.25M in profits. Earnings per share was -0.67.

Revenue
0
Gross Profit
-888.00K
Operating Income
-74.13M
Pretax Income
-76.72M
Net Income
-76.25M
EBITDA
-73.24M
Earnings Per Share (EPS)
-0.67

Cash Flow

In the last 12 months, operating cash flow was -61.66M and capital expenditures 0, giving a free cash flow of -61.66M billion.

Operating Cash Flow
-61.66M
Free Cash Flow
-61.66M
Free Cash Flow per Share
-0.48

Dividends & Yields

Ascelia Pharma AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-79.61%
Earnings Yield
-73.36%

Stock Price Statistics

Beta
55.11
52-Week Price Change
-83.88%
50-Day Moving Average
0.05
200-Day Moving Average
0.14
Relative Strength Index (RSI)
38.31
Average Volume (3m)
13.00K

Important Dates

Ascelia Pharma AB upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 11, 2027
Ex-Dividend Date
―

Financial Position

Ascelia Pharma AB as a current ratio of 4.35, with Debt / Equity ratio of 1.05%

Current Ratio
4.35
Quick Ratio
4.35
Debt to Market Cap
0.00
Net Debt to EBITDA
0.67
Interest Coverage Ratio
-13.46

Taxes

In the past 12 months, Ascelia Pharma AB has paid -468.00K in taxes.

Income Tax
-468.00K
Effective Tax Rate
0.01

Enterprise Valuation

Ascelia Pharma AB EV to EBITDA ratio is -0.90, with an EV/FCF ratio of -0.81.

EV to Sales
0.00
EV to EBITDA
-0.90
EV to Free Cash Flow
-0.81
EV to Operating Cash Flow
-0.81

Balance Sheet

Ascelia Pharma AB has EUR 27.80M in cash and marketable securities with EUR 285.00K in debt, giving a net cash position of EUR 27.52M billion.

Cash & Marketable Securities
EUR 27.80M
Total Debt
EUR 285.00K
Net Cash
EUR 27.52M
Net Cash Per Share
EUR 0.21
Tangible Book Value Per Share
EUR 0.18

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Ascelia Pharma AB is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
49.02%